Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

Clinical trial NCT03423706 · UNKNOWN

Trial details

NCT number: NCT03423706
Sponsor: First Affiliated Hospital of Harbin Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

CD19-chimeric Antigen Receptor T Cells Relapsed and/or Refractory Acute Lymphoblastic Leukemia the Haploidentical Hematopoietic Stem Cell Transplantation

Start date: 2018-05-07
Primary completion: 2020-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.